GLS1 Inhibitor
- CAS No.
- 1832646-52-2
- Chemical Name:
- GLS1 Inhibitor
- Synonyms
- GLS1 Inhibitor,GLS-1 Inhibitor;4-thiadiazol-2-yl]-benzeneacetamide;αS-methoxy-N-[5-[[(3R)-1-(3-pyridazinyl)-3-pyrrolidinyl]amino]-1;ΑS-METHOXY-N-[5-[[(3R)-1-(3-PYRIDAZINYL)-3-PYRROLIDINYL]AMINO]-1;3;4-THIADIAZOL-2-YL]-BENZENEACETAMIDE;Benzeneacetamide, α-methoxy-N-[5-[[(3R)-1-(3-pyridazinyl)-3-pyrrolidinyl]amino]-1,3,4-thiadiazol-2-yl]-, (αS)-;(2S)-2-methoxy-2-phenyl-N-(5-{[(3R)-1-(pyridazin-3-yl)pyrrolidin-3-yl]amino}-1,3,4-thiadiazol-2-yl)acetamide - [AC78023]
- CBNumber:
- CB75582380
- Molecular Formula:
- C19H21N7O2S
- Molecular Weight:
- 411.48
- MDL Number:
- MOL File:
- 1832646-52-2.mol
- MSDS File:
- SDS
GLS1 Inhibitor price More Price(20)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 28581 | GLS1 Inhibitor ≥98% | 1832646-52-2 | 1mg | $36 | 2026-04-30 | Buy |
| Cayman Chemical | 28581 | GLS1 Inhibitor ≥98% | 1832646-52-2 | 5mg | $103 | 2026-04-30 | Buy |
| Cayman Chemical | 28581 | GLS1 Inhibitor ≥98% | 1832646-52-2 | 10mg | $153 | 2026-04-30 | Buy |
| ChemScene | CS-0133394 | GLS1 Inhibitor-1 98.5% | 1832646-52-2 | 5mg | $233 | 2026-06-04 | Buy |
| ChemScene | CS-0133394 | GLS1 Inhibitor-1 98.5% | 1832646-52-2 | 10mg | $379 | 2026-06-04 | Buy |
GLS1 Inhibitor Chemical Properties, Uses, Production
Description
GLS1 inhibitor is an inhibitor of glutaminase 1 (GLS1; IC50 = 0.021 μM). It inhibits the growth of NCI H1703 non-small cell lung cancer (NSCLC) cells in vitro (GI50 = 0.011 μM). GLS1 inhibitor (100 mg/kg) reduces tumor growth, increases tumor levels of glutamine, and decreases tumor levels of glutamate and aspartate in an NCI H1703 mouse xenograft model.
Uses
GLS1 Inhibitor-1 (Compound 27) is an orally active inhibitor for glutaminase 1 (GLS1) with an IC50 of 0.021 μM. GLS1 Inhibitor-1 inhibits the proliferation of PC-3 with an IC50 of 0.3 nM. GLS1 Inhibitor-1 exhibits antitumor efficacy against NCI-H1703 with GI50 of 0.011 μM. GLS1 Inhibitor-1 exhibits moderate pharmacokinetic characteristics[1].
References
[1] Finlay MRV, et al., Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models. J Med Chem. 2019 Jul 25;62(14):6540-6560. DOI:10.1021/acs.jmedchem.9b00260
GLS1 Inhibitor Preparation Products And Raw materials
Raw materials
Preparation Products
GLS1 Inhibitor Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11123 | 58 |
| TargetMol Chemicals Inc. | 4008200310 15002144251 | marketing@tsbiochem.com | China | 24951 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
| Supplier | Advantage |
|---|---|
| TargetMol Chemicals Inc. | 58 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 58 |
| TargetMol Chemicals Inc. | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 58 |
View Latest Price from GLS1 Inhibitor manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-15 | GLS1 Inhibitor
1832646-52-2
|
$113.00-493.00 | 10g | TargetMol Chemicals Inc. |
-

- GLS1 Inhibitor
1832646-52-2
- $113.00-493.00
- TargetMol Chemicals Inc.




